Latest News

What SiTime’s latest quarter means for investors SiTime (SITM) has moved into focus after its fourth quarter 2025 report showed earnings per share and revenue ahead of market expectations, drawing increased attention to the stock and the company’s financial profile. For you as an investor, that beat on both the top and bottom line raises fresh questions about how SiTime’s US$9.1b valuation, recent returns and expanding operations might align with your own risk tolerance and time horizon. See...

Why Stoke Therapeutics Matters For Genetic Disease Investors Stoke Therapeutics (STOK) has drawn attention as a clinical stage biotech focused on severe genetic diseases, with lead programs targeting Dravet syndrome and autosomal dominant optic atrophy using its TANGO RNA platform. For investors, the current interest centers on how this specialized focus, combined with Stoke’s clinical pipeline and existing collaborations with Biogen and Acadia Pharmaceuticals, aligns with recent share price...

Furukawa Electric Co., Ltd. previously held a board meeting on March 27, 2026 to consider waiving claims against one of its equity method affiliates, signaling a potentially significant intra-group financial decision. The move to consider relinquishing claims against an affiliate is unusual and could meaningfully reshape how Furukawa Electric’s exposures and relationships within its corporate network are viewed. We will now examine how the potential waiver of claims against this equity...

How Sonic Automotive Stock Has Been Performing Sonic Automotive (SAH) has drawn investor attention after a mixed stretch in its share price, with a small 1 day decline and a slightly larger pullback over the past week. Even with this short term softness, the stock shows a gain over the past month and the past 3 months, alongside a positive total return over the past year and over multiple year periods. See our latest analysis for Sonic Automotive. The recent 1 day and 7 day share price...

The UK market has recently experienced a downturn, with the FTSE 100 and FTSE 250 indices closing lower due to weak trade data from China, highlighting global economic challenges. Despite these broader market conditions, there are still opportunities for investors willing to explore smaller or newer companies. Penny stocks, although an older term, continue to represent potential growth opportunities at lower price points when backed by strong financials and solid fundamentals.

M/I Homes recently experienced a softer trading session, as analysts signaled caution ahead of its April 22, 2026 earnings report with expectations of lower earnings per share and a Zacks Rank of #4 (Sell) reflecting more guarded sentiment. This shift in analyst expectations highlights how quickly confidence in a homebuilder’s near-term performance can adjust when earnings trends appear to be weakening. With analysts now expecting declining near-term earnings, we’ll examine how this more...

Recently, investment analysts downgraded Green Plains from Buy to Hold, citing increased competition in the biofuels sector and uncertainty around future regulations despite the company’s ongoing diversification into renewable fuels and higher-value products. What stands out is that skepticism is growing even as Green Plains invests in expanding low-carbon fuel operations, highlighting how sensitive its outlook remains to policy and industry conditions. We’ll now explore how this fresh...

Meshek Energy - Renewable Energies (TASE:MSKE) has released its full year 2025 results, reporting ILS 137.48 million in revenue and a net loss of ILS 86.81 million, which may lead to a mixed reaction from investors. See our latest analysis for Meshek Energy - Renewable Energies. The earnings release comes after a strong run, with a 90 day share price return of 29.26% and a very large 1 year total shareholder return. However, the 30 day share price return of a 13.66% decline suggests momentum...

Rapport Therapeutics (RAPP) is back in focus after outlining new milestones for its lead asset, RAP-219, including a Phase 2a data presentation and earlier than planned Phase 3 trial timelines. See our latest analysis for Rapport Therapeutics. RAPP shares recently closed at $33.58, with a 1-day share price return of 6.03% and a 7-day share price return of 21.27%. The 1-year total shareholder return of 253.10% reflects strong momentum around the RAP-219 program and its clinical milestones. If...

Readers hoping to buy Accenture plc ( NYSE:ACN ) for its dividend will need to make their move shortly, as the stock is...

As the Canadian TSX index shows signs of recovery amid lingering uncertainties and elevated oil prices, investors are closely monitoring the potential impacts of global events on market stability. In such a climate, identifying undervalued stocks becomes crucial, as these equities may offer opportunities for growth despite broader economic challenges.

As Canadian markets have shown resilience by rebounding from recent lows, the focus remains on how prolonged oil price fluctuations might impact economic growth. Amidst this backdrop, growth companies with significant insider ownership can be appealing as they often signal confidence in the company's potential and align interests between management and shareholders.

By the end of last week, markets rebounded from the lows, and the S&P 500 and Canadian TSX indexes were positive for the week, after negative returns in March. Despite ongoing concerns about oil prices and economic uncertainty, there are signs that de-escalation could lead to more stable conditions. In this context, penny stocks—often smaller or newer companies—remain a relevant investment area due to their potential for significant returns when backed by solid financials.

Candy makers, including Tootsie Roll Industries, have recently benefited from sector-wide momentum as seasonal demand and pricing power helped offset higher input costs, while the rescinding of cocoa tariffs is expected to ease cost pressures in 2026. For Tootsie Roll, this combination of niche brand appeal and potentially lower cocoa-related expenses adds a fresh dimension to how investors may assess its competitive position. We’ll now examine how easing cocoa tariffs could influence...

Rosen Law Firm recently announced it is investigating potential securities claims against DNOW Inc., focusing on whether the company issued materially misleading business information to investors. This kind of legal scrutiny can raise questions about the reliability of DNOW’s prior disclosures, which matter for investors assessing its business quality and governance. With a securities law firm now probing DNOW’s disclosures, we’ll explore how this added litigation risk affects the company’s...

In recent days, UDR, Inc. reported strong Q4 2025 earnings, expanded a joint venture, and approved a 1.2% increase in its quarterly dividend, signaling continued commitment to shareholder payouts. Yet this positive operational update coincided with analysts trimming growth expectations while hedge funds increased their positions, highlighting a tension between cautious forecasts and renewed institutional interest. Next, we’ll explore how this combination of stronger earnings and a higher...

In early 2026, Adaptive Biotechnologies reported fourth-quarter 2025 earnings that exceeded analyst expectations, highlighted by strong Minimal Residual Disease (MRD) revenue growth, while senior executives including President and COO Julie Rubinstein and Chief Scientific Officer Harlan S. Robins sold shares under pre-arranged trading plans totaling more than US$1,350,000. A pair of non-exclusive agreements with Pfizer, covering T-cell receptor discovery and immune data licensing with...

WHSP Holdings (ASX:SOL) has drawn fresh attention after reporting half year sales of A$620 million and net income of A$2,303 million, along with a higher interim dividend of A$0.48 per share. See our latest analysis for WHSP Holdings. The recent half year result and higher interim dividend have arrived alongside firm share price momentum, with a 10.6% year to date share price return and a 23.4% total shareholder return over the past year signalling strengthening interest from investors. If...

The United States market has shown strong performance recently, climbing 3.5% in the last week and 31% over the past year, with earnings projected to grow by 16% annually in the coming years. In such a dynamic environment, identifying stocks that are potentially undervalued can be crucial for investors looking to capitalize on growth opportunities across various regions.

The United States market has experienced a notable upswing, rising 3.5% over the past week and an impressive 31% over the last year, with earnings projected to grow by 16% annually. In this thriving environment, identifying high growth tech stocks involves looking for companies that not only capitalize on current technological trends but also demonstrate strong potential for sustained revenue expansion and innovation.

The United States market has shown a robust performance, rising 3.5% over the last week and 31% over the past year, with earnings projected to grow by 16% annually. In such a thriving environment, identifying stocks that are trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on market inefficiencies.

The United States market has recently experienced a notable upswing, climbing 3.5% in the last week and showing an impressive 31% increase over the past year, with earnings projected to grow by 16% annually. In this thriving environment, identifying growth companies with substantial insider ownership can be a promising strategy, as it often indicates management's confidence in the company's future prospects.

Over the last 7 days, the United States market has risen by 3.5%, contributing to a 31% increase over the past year, with earnings projected to grow annually by 16%. Penny stocks may be a throwback term, but they still represent significant opportunities for investors seeking growth at lower price points. By focusing on companies with strong financials and solid fundamentals, these stocks can offer potential upside while mitigating some of the risks typically associated with this investment...

The United States market has experienced a robust performance, rising 3.5% over the last week and climbing 31% over the past year, with earnings projected to grow by 16% annually. In this thriving environment, identifying promising small-cap stocks can be key to unlocking potential opportunities that may not yet be fully recognized by the broader market.